700 attendees, over 90 presentations, many new contacts made and much champagne enjoyed - did you miss out on joining us in Champagne-Ardenne?
Champagne-Ardenne was an impressive host to the 7th annual European Forum for Industrial Biotechnology and the Biobased Economy, and the congress was officially opened by the President of the Regional Council of Champagne-Ardenne, Mr Jean-Paul Bachy...read more>>
Mr Bachy comments "It was my pleasure to open this prestigious meeting for the biobased economy, which is an opportunity for unprecedented exchanges with leading international experts. Champagne-Ardenne is dedicated to advancing the use of biobased technologies throughout Europe and we were glad to be able to showcase our capabilities at this great event."
If you weren't amongst the 700 biobased professionals, you missed the champagne drinks reception at the historic Palais du Tau and your chance to network with companies such as Nike, Givaudan, DSM, Novozymes, Faurecia, Unilever and more! See who was in Reims >>
The biggest agenda yet!
Over 90 speakers joined us in October, for an insight into this exciting and rapidly evolving landscape and to be part of the process of building a stronger more sustainable biobased economy.
Speaking across the 8 tracks, plenary programmes and pre-conference workshops, VP level representatives from leading companies DSM and Arkema, plus CEOs of successful SMEs Cristal Union, Photanol, MetGen and presented unique insights and case studies of innovative biobased projects!
View the full agenda for 2014 >> and Download the post event summary here >>
Exclusive DSM Project Liberty Whitepaper
DSM have put together a White Paper - Project Liberty: The Start of the Cellulosic Ethanol Revolution which explores the journey taken to create Project Liberty and the implications of its opening for the US and Europe.
Download the white paper here
Have you missed recent EFIB content? Read it here!
The EFIB team are committed to bringing you the most relevant and topical contact relating to the biobased economy and the field of industrial biotechnology, and each week have brought you speaker interviews, opinion articles and more. Highlights of these features, can be accessed below:
Interviews with Ron Weerdmeester, PNO and Rogier van der Sande, Committee of the Regions
European Bioplastics: Investment in IB and the future of biobased plastics in Europe
Industrial biotechnology and the biobased economy: High growth rates and capacity potential estimated
EFIB took place during Biorefinery week
This year's event partners IAR ran a biorefinery week in Reims, during the week of EFIB. The week consisted of tours to local biorefinery plants, workshops and one day meetings in the heart of the Champagne-Ardenne region. View more information on what took place in Reims in October here >>
What happened at EFIB 2013?
The European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) opened to a record delegation last year in Brussels at The Square. Then in its 6th year, EFIB had successfully made the transformation from a small specialised conference to a market leading, pan European flagship event for the vibrant and dynamic sector of Europe's bioeconomy.
The event took place during the first ever European Biotech Week, and had 700 delegates in attendance all on site to gain access to the market place of 45 exhibitors and 20 technology showcase presentations. They took place alongside a formidable programme of senior leaders including Belgian Ministers, a record number of European policy makers and CEOs from Galactic, Ecover and several other multinational companies.
Read more about EFIB's record year
Read the full review on what happened at EFIB 2013
Global Partnerships and Alliances Key to Industrial Biotechnology Futures
Key drivers behind new partnerships and alliances in industrial biotechnology will be the need to access raw materials and technology at the required cost and amount and exposure to diversified markets, according to new forecasts by Smithers Rapra.
The Future of Alliances and Partnerships in Industrial Biotechnology to 2023 contains details of the competitive biotechnology landscape and quantitative forecasts until 2023, as well as details of emerging markets. It includes extensive primary research, and reveals what will be essential for the dynamic biotechnology industry in years to come.
Read more here
Keep up with the conversation and follow us on LinkedIn and Twitter
|In association with: |